Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban
Background. Anticoagulation with warfarin remains the mainstay treatment for left ventricular thrombi. Although successful thrombus resolution has been reported with direct oral anticoagulants’ (DOACs’) recurrence/progression while resuming Apixaban therapy is yet to be reported. Case Presentation....
Saved in:
Main Authors: | Azhar Farooqui, Tin Lwin, Daniel Costa, Simon Hetherington, Raj Mattu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2022/8156942 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aftermath of Apixaban: Atypical Anticoagulation Aftereffect
by: Bhesh Karki, et al.
Published: (2022-01-01) -
Spontaneous Adrenal Hemorrhage with Mild Hypoadrenalism in a Patient Anticoagulated with Apixaban for Antiphospholipid Syndrome: A Case Report and Literature Review
by: Jia Wei Tan, et al.
Published: (2022-01-01) -
Case Report of a Massive Thigh Hematoma after Adductor Canal Block in a Morbidly Obese Woman Anticoagulated with Apixaban
by: Katherine L. Koniuch, et al.
Published: (2018-01-01) -
A Giant Right Heart Thrombus-in-Transit: The Challenge of Anticoagulation in Factor V Leiden Thrombophilia
by: Andrew Chu, et al.
Published: (2018-01-01) -
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World Studies
by: Olivia Wu, et al.
Published: (2022-01-01)